Cimzia (certolizumab pegol) - Astellas, UCB
Rheumatoid Factors (RFs) Do Not Bind Fc‑Free Certolizumab Pegol, but Do Bind to Fc‑Containing Biological DMARDs, Leading to Immune Complex Formation Which Induces Cytokine Release from Human Peripheral Blood Mononuclear Cells (PBMC) In Vitro (ACR Convergence 2026) - Sep 8, 2026 - Abstract #101; Pres time: Nov 8, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Preclinical • Immunology
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3569424
 
David Humphreys, PhD, BSc
 
Sep 8, 2026
 
Prev Next